hims & hers semaglutide makes deal with Novo in obesity strategy shift Hims offers cheapest GLP-1 weight-loss

Diagnosis and referral economics For rare diseases, revenue growth often tracks: Increased genetic testing throughput for obesity cohorts Referral concentration in tertiary centers Programmatic patient support that converts identified to treated Impact on trajectory: Each incremental center or testing pathway can add patients faster than the broader population, so sales growth can accelerate when referral networks broaden

ask your clinician about short-term anti-nausea options if needed

Keep products in their original containers

Many people compare GLP-1 weight-loss pills to weekly injections like Wegovy and Mounjaro to understand which option delivers stronger or more convenient results